25/05/2023.

Skin cancer is one of the most common types of all cancers. Melanoma may be the rarest subtype, but it will be responsible for over 7000 deaths this year, in the United States alone. Here’s the better news.

23/05/2023.

In the recent decade, deep neural networks (DNNs) have successfully been applied to a multitude of tasks both in research and industry.

20/05/2023.

iToBoS was discussed in a presentation at the EADV (European Academy of Dermatology and Venereology) Symposium, held at Seville, Spain in May, 2023, and hosted by the AEDV (The Spanish Academy of Dermatology and Venereology).

19/05/2023.

Detecting overfitting is technically not possible unless we test the data.

16/05/2023.

Out of all the things that can go wrong with your ML model, overfitting is one of the most common and most detrimental errors. The bad news is that this time, it's not an exaggeration.

12/05/2023.

Image relighting is the task of simulating a light source change in an image. It is an inverse challenging problem that is usually solved by estimating the image geometry, the reflectance and the lighting. Usually, the results contain artifacts that makes the output look unrealistic.

11/05/2023.

iToBoS project presents the second out of a series of three online educational modules for the European Melanoma patient community. The kick-off session was on May 11th, 2023.

10/05/2023.

Prof. Rafael Garcia (University of Girona), coordinator of iToBoS project, attended the annual Conference of the European Association of Melanoma Patients (MPNE 2023).

8/05/2023.

As part of iToBoS educational module prs4pa- polygenic risk scores for patient advocates- we will be reading 'Understand your DNA' as an introduction to genetics in the form of a book club.

6/05/2023.

University of Trieste, partner of iToBoS project, organized in Trieste the Master Course IMI on the management of melanoma and non-melanoma skin cancers patients.